11 Einträge gefunden

1. p53 overexpression is a prognosticator of poor outcome in esophageal cancer

   1. Melling, Nathaniel
   2. Norrenbrock, Sonja
   3. Kluth, Martina
   4. Simon, Ronald
   5. Hube-Magg, Claudia
   6. Steurer, Stefan
   7. Hinsch, Andrea

   2019 - Forschungsinformationssystem des UKE
2. Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer

   1. Burdelski, Christoph
   2. Borcherding, Laura
   3. Kluth, Martina
   4. Hube-Magg, Claudia
   5. Melling, Nathaniel
   6. Simon, Ronald
   7. Möller-Koop, Christina

   2017 - Forschungsinformationssystem des UKE
3. High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer

   1. Melling, Nathaniel
   2. Rashed, Masoud
   3. Schroeder, Cornelia
   4. Hube-Magg, Claudia
   5. Kluth, Martina
   6. Lang, Dagmar
   7. Simon, Ronald

   2017 - Forschungsinformationssystem des UKE - frei zugänglich
4. Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer

   1. Jacobsen, Frank
   2. Taskin, Billurvan
   3. Melling, Nathaniel
   4. Sauer, Charlotte
   5. Wittmer, Corinna
   6. Hube-Magg, Claudia
   7. Kluth, Martina

   2017 - Forschungsinformationssystem des UKE - frei zugänglich
5. Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer

   1. Melling, Nathaniel
   2. Taskin, B
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Minner, Sarah
   6. Koop, Christina
   7. Grob, Tobias

   2016 - Forschungsinformationssystem des UKE
6. The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

   1. Burdelski, Christoph
   2. Menan, Devi
   3. Tsourlakis, Maria Christina
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Melling, Nathaniel
   7. Minner, Sarah

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
7. Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers

   1. Burdelski, Christoph
   2. Bujupi, Erzen
   3. Tsourlakis, Maria Christina
   4. Hube-Magg, Claudia
   5. Kluth, Martina
   6. Melling, Nathaniel
   7. Lebok, Patrick

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
8. Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

   1. Melling, Nathaniel
   2. Thomsen, Erik
   3. Tsourlakis, Maria Christina
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Minner, Sarah
   7. Koop, Christina

   2015 - Forschungsinformationssystem des UKE
9. High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer

   1. Melling, Nathaniel
   2. Harutyunyan, Levon
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Lebok, Patrick
   7. Minner, Sarah

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
10. HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer

    1. Burdelski, Christoph
    2. Ruge, Oliver M
    3. Melling, Nathaniel
    4. Koop, Christina
    5. Simon, Ronald
    6. Steurer, Stefan
    7. Sauter, Guido

    2015 - Forschungsinformationssystem des UKE
11. Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer

    1. Burdelski, Christoph
    2. Strauss, Christian
    3. Tsourlakis, Maria Christina
    4. Kluth, Martina
    5. Hube-Magg, Claudia
    6. Melling, Nathaniel
    7. Lebok, Patrick

    2015 - Forschungsinformationssystem des UKE